Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • MurielGB
    Member
    • Oct 2013
    • 51

    #1

    Remapping

    Hello !

    I have Illumina sequences that I have to remap onto the reference genome.
    First I want to trim the data according to quality and length using Sickle.
    Apparently, the treshold mostly used for quality is 20.

    But what about length ???
    I beleive that if I keep too short sequences they will map in different places in the reference genome and tgis is not good.
    But what treshold use ?
    35 ?

    I have to say that I have different runs with different read length (from 41 to 84).

    Thanks a lot for your help.

    Muriel
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    It sort of depends on what you intend to do downstream with the data. If you're going to be doing something that doesn't pay attention to MAPQ, then you shouldn't set anything too short (maybe 30 or so?). Otherwise, multimappers will just be ignored anyway due to their very low MAPQs, so 20 or so is probably OK, depending on the genome.

    Comment

    • MurielGB
      Member
      • Oct 2013
      • 51

      #3
      Thanks dpryan for your answer.

      The aim of the analysis is to call variants.

      I plan indeed to check the quality of the mapping if this is what you mean by MAPQ though I don't know yet which software I am gonna use.

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        I know that in the case of the UnifiedGenotyper in GATK, the maximum Phred score of a base (used in SNP calling) is capped to the MAPQ, which is a mapping quality (the 5th column in a SAM file). With samtools mpileup, there's the -q option (though its default is 0).

        Comment

        • MurielGB
          Member
          • Oct 2013
          • 51

          #5
          OK thanks a lot !

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 11:13 AM
          0 responses
          19 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, Yesterday, 10:48 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          42 views
          0 reactions
          Last Post SEQadmin2  
          Working...